BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35271701)

  • 1. Concordance in Breast Cancer Grading by Artificial Intelligence on Whole Slide Images Compares With a Multi-Institutional Cohort of Breast Pathologists.
    Mantrala S; Ginter PS; Mitkari A; Joshi S; Prabhala H; Ramachandra V; Kini L; Idress R; D'Alfonso TM; Fineberg S; Jaffer S; Sattar AK; Chagpar AB; Wilson P; Singh K; Harigopal M; Koka D
    Arch Pathol Lab Med; 2022 Nov; 146(11):1369-1377. PubMed ID: 35271701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy.
    Ginter PS; Idress R; D'Alfonso TM; Fineberg S; Jaffer S; Sattar AK; Chagpar A; Wilson P; Harigopal M
    Mod Pathol; 2021 Apr; 34(4):701-709. PubMed ID: 33077923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
    Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
    JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning supported mitoses counting on whole slide images: A pilot study for validating breast cancer grading in the clinical workflow.
    van Bergeijk SA; Stathonikos N; Ter Hoeve ND; Lafarge MW; Nguyen TQ; van Diest PJ; Veta M
    J Pathol Inform; 2023; 14():100316. PubMed ID: 37273455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases.
    Jung M; Song SG; Cho SI; Shin S; Lee T; Jung W; Lee H; Park J; Song S; Park G; Song H; Park S; Lee J; Kang M; Park J; Pereira S; Yoo D; Chung K; Ali SM; Kim SW
    Breast Cancer Res; 2024 Feb; 26(1):31. PubMed ID: 38395930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer histologic grading using digital microscopy: concordance and outcome association.
    Rakha EA; Aleskandarani M; Toss MS; Green AR; Ball G; Ellis IO; Dalton LW
    J Clin Pathol; 2018 Aug; 71(8):680-686. PubMed ID: 29535212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Prognostic Factors in the Digital Era: Comparison of Nottingham Grade using Whole Slide Images and Glass Slides.
    Davidson TM; Rendi MH; Frederick PD; Onega T; Allison KH; Mercan E; Brunyé TT; Shapiro LG; Weaver DL; Elmore JG
    J Pathol Inform; 2019; 10():11. PubMed ID: 31057980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver variability in breast carcinoma grading results in prognostic stage differences.
    Rabe K; Snir OL; Bossuyt V; Harigopal M; Celli R; Reisenbichler ES
    Hum Pathol; 2019 Dec; 94():51-57. PubMed ID: 31655171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study.
    Yue M; Zhang J; Wang X; Yan K; Cai L; Tian K; Niu S; Han X; Yu Y; Huang J; Han D; Yao J; Liu Y
    Virchows Arch; 2021 Sep; 479(3):443-449. PubMed ID: 34279719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Ki67 assessment concordance by the use of an artificial intelligence-empowered microscope: a multi-institutional ring study.
    Cai L; Yan K; Bu H; Yue M; Dong P; Wang X; Li L; Tian K; Shen H; Zhang J; Shang J; Niu S; Han D; Ren C; Huang J; Han X; Yao J; Liu Y
    Histopathology; 2021 Oct; 79(4):544-555. PubMed ID: 33840132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses.
    Pantanowitz L; Hartman D; Qi Y; Cho EY; Suh B; Paeng K; Dhir R; Michelow P; Hazelhurst S; Song SY; Cho SY
    Diagn Pathol; 2020 Jul; 15(1):80. PubMed ID: 32622359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.
    Zaakouk M; Quinn C; Provenzano E; Boyd C; Callagy G; Elsheikh S; Flint J; Millican-Slater R; Gunavardhan A; Mir Y; Makhija P; Di Palma S; Pritchard S; Tanchel B; Rakha E; Atallah NM; Lee AHS; Pinder S; Shaaban AM
    Breast; 2023 Aug; 70():82-91. PubMed ID: 37419078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology.
    Eminaga O; Abbas M; Kunder C; Tolkach Y; Han R; Brooks JD; Nolley R; Semjonow A; Boegemann M; West R; Long J; Fan RE; Bettendorf O
    Sci Rep; 2024 Mar; 14(1):5284. PubMed ID: 38438436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.
    Frierson HF; Wolber RA; Berean KW; Franquemont DW; Gaffey MJ; Boyd JC; Wilbur DC
    Am J Clin Pathol; 1995 Feb; 103(2):195-8. PubMed ID: 7856562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning-based breast cancer grading and survival analysis on whole-slide histopathology images.
    Wetstein SC; de Jong VMT; Stathonikos N; Opdam M; Dackus GMHE; Pluim JPW; van Diest PJ; Veta M
    Sci Rep; 2022 Sep; 12(1):15102. PubMed ID: 36068311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
    Van Bockstal M; Baldewijns M; Colpaert C; Dano H; Floris G; Galant C; Lambein K; Peeters D; Van Renterghem S; Van Rompuy AS; Verbeke S; Verschuere S; Van Dorpe J
    Histopathology; 2018 Dec; 73(6):923-932. PubMed ID: 30168167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence-powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response.
    Choi S; Cho SI; Ma M; Park S; Pereira S; Aum BJ; Shin S; Paeng K; Yoo D; Jung W; Ock CY; Lee SH; Choi YL; Chung JH; Mok TS; Kim H; Kim S
    Eur J Cancer; 2022 Jul; 170():17-26. PubMed ID: 35576849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.
    Abele N; Tiemann K; Krech T; Wellmann A; Schaaf C; Länger F; Peters A; Donner A; Keil F; Daifalla K; Mackens M; Mamilos A; Minin E; Krümmelbein M; Krause L; Stark M; Zapf A; Päpper M; Hartmann A; Lang T
    Mod Pathol; 2023 Mar; 36(3):100033. PubMed ID: 36931740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors.
    Palm C; Connolly CE; Masser R; Padberg Sgier B; Karamitopoulou E; Simon Q; Bode B; Tinguely M
    Diagnostics (Basel); 2023 Jan; 13(1):. PubMed ID: 36611460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application Test of the AI-Automatic Diagnostic System for Ki-67 in Breast Cancer].
    Deng Y; Li FL; Qin HY; Zhou YY; Zhou QQ; Mei J; Li L; Liu HH; Wang YZ; Bu H; Bao J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):693-697. PubMed ID: 34323051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.